Back to search

Article

Towards Preclinical Validation of Arbaclofen (R-baclofen) Treatment for 16p11.2 Deletion Syndrome

2023-05-02

Abstract excerpt

A microdeletion on human chromosome 16p11.2 is one of the most common copy number variants associated with autism spectrum disorder and other neurodevelopmental disabilities. Arbaclofen, a GABA(B) receptor agonist, is a component of racemic baclofen, which is FDA-approved for treating spasticity, and has been shown to alleviate behavioral phenotypes, including recognition memory deficits, in animal models of 16p11...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5902f0ed-8e45-5887-99aa-347cb512433e
DOI
10.1101/2023.05.01.538987
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Towards Preclinical Validation of Arbaclofen (R-baclofen) Treatment for 16p11.2 Deletion SyndromeDOI 10.1101/2023.05.01.538987
Select a neighboring publication to make it the new centre.